Effects of the CALM intervention on cancer-related fatigue and heart rate variability in NSCLC: a randomized trial.

IF 3 4区医学 Q2 ONCOLOGY

Future oncology Pub Date : 2024-11-15 DOI:10.1080/14796694.2024.2428586

Jiaying Chai, Chen Gan, Yingxue Jia, Runze Huang, Anlong Li, Han Ge, Xinyi Zheng, Lijun Liu, Jian Xu, Ling Cheng, Huaidong Cheng

{"title":"Effects of the CALM intervention on cancer-related fatigue and heart rate variability in NSCLC: a randomized trial.","authors":"Jiaying Chai, Chen Gan, Yingxue Jia, Runze Huang, Anlong Li, Han Ge, Xinyi Zheng, Lijun Liu, Jian Xu, Ling Cheng, Huaidong Cheng","doi":"10.1080/14796694.2024.2428586","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate the effects of CALM intervention on cancer-related fatigue (CRF), quality of life (QOL), and heart rate variability (HRV) in non-small cell lung cancer (NSCLC) patients.Methods: A total of 153 NSCLC patients were enrolled in the study. Participants were randomly assigned to the CALM group and usual care (UC) group. Patients in the CALM group were received 6 CALM intervention sessions over a 12-week period and evaluated using CRF, QOL and HRV at baseline (T0) and after 2, 4, and 6 intervention sessions.Results: The CALM group showed significant differences in total CRF, behavioral/daily life CRF, emotional/affective CRF, sensory/physical CRF, cognitive CRF and QOL before and after CALM intervention sessions (F = 643.47, F = 208.34, F = 354.52, F = 285.69, F = 334.29, F = 245.77, p < 0.001). The CALM group showed significant increases in standard deviation of normal R-R interval (SDNN) and high-frequency power (HF) (z = -4.94, p < 0.001,z = -4.30, p < 0.001). Significant negative correlations were observed between CRF and SDNN, HF and QOL across all participants.Conclusions: The CALM intervention had a positive impact on overall physical and mental health, fatigue reduction, quality of life and autonomic dysfunction in NSCLC patients. Heart rate variability may serve as an observational indicator of physical and mental health.","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"1-12"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2024.2428586","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To evaluate the effects of CALM intervention on cancer-related fatigue (CRF), quality of life (QOL), and heart rate variability (HRV) in non-small cell lung cancer (NSCLC) patients.

Methods: A total of 153 NSCLC patients were enrolled in the study. Participants were randomly assigned to the CALM group and usual care (UC) group. Patients in the CALM group were received 6 CALM intervention sessions over a 12-week period and evaluated using CRF, QOL and HRV at baseline (T0) and after 2, 4, and 6 intervention sessions.

Results: The CALM group showed significant differences in total CRF, behavioral/daily life CRF, emotional/affective CRF, sensory/physical CRF, cognitive CRF and QOL before and after CALM intervention sessions (F = 643.47, F = 208.34, F = 354.52, F = 285.69, F = 334.29, F = 245.77, p < 0.001). The CALM group showed significant increases in standard deviation of normal R-R interval (SDNN) and high-frequency power (HF) (z = -4.94, p < 0.001,z = -4.30, p < 0.001). Significant negative correlations were observed between CRF and SDNN, HF and QOL across all participants.

Conclusions: The CALM intervention had a positive impact on overall physical and mental health, fatigue reduction, quality of life and autonomic dysfunction in NSCLC patients. Heart rate variability may serve as an observational indicator of physical and mental health.

查看原文本刊更多论文

CALM干预对NSCLC癌症相关疲劳和心率变异性的影响：随机试验。

目的评估CALM干预对非小细胞肺癌（NSCLC）患者癌症相关疲劳（CRF）、生活质量（QOL）和心率变异性（HRV）的影响：研究共招募了 153 名 NSCLC 患者。参与者被随机分配到CALM组和常规护理（UC）组。CALM组患者在12周内接受6次CALM干预治疗，并在基线（T0）和2、4、6次干预治疗后使用CRF、QOL和心率变异进行评估：CALM组在总CRF、行为/日常生活CRF、情绪/情感CRF、感觉/身体CRF、认知CRF和QOL方面在CALM干预前后均有显著差异（F = 643.47, F = 208.34, F = 354.52, F = 285.69, F = 334.29, F = 245.77, p p p结论：CALM干预对NSCLC患者的整体身心健康、疲劳减轻、生活质量和自主神经功能障碍有积极影响。心率变异性可作为身心健康的观察指标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future oncology ONCOLOGY-

CiteScore

5.40

自引率

3.00%

发文量

335

审稿时长

4-8 weeks

期刊介绍： Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.